首页 | 本学科首页   官方微博 | 高级检索  
     

羟基喜树碱联合化疗治疗中晚期消化道肿瘤的疗效观察
引用本文:李红,樊青霞,杨峰. 羟基喜树碱联合化疗治疗中晚期消化道肿瘤的疗效观察[J]. 现代肿瘤医学, 2007, 15(6): 819-820
作者姓名:李红  樊青霞  杨峰
作者单位:1. 郑州大学第一附属医院,河南,郑州,450008;河南省肿瘤医院中西医结合科,河南,郑州,450052
2. 郑州大学第一附属医院,河南,郑州,450008
3. 河南省肿瘤医院中西医结合科,河南,郑州,450052
摘    要:目的:观察使用羟基喜树碱(HCPT)治疗中晚期消化道肿瘤的疗效与毒性。方法:中晚期消化道肿瘤患者119例,不同病种采用不同的化疗方案,每21d为1周期,4周期为1疗程评价疗效。结果:总有效率54.6%,其中胃癌尤为明显,有效率63.3%。主要不良反应为白细胞减少和胃肠道反应。结论:HCPT联合化疗治疗中晚期消化道肿瘤患者安全有效,与其他抗癌药无交叉耐药性。

关 键 词:消化系统肿瘤  联合化疗
文章编号:1672-4992-(2007)06-0819-02
修稿时间:2006-11-072006-12-12

Efficacy of hydroxycamptothecin combined with chemotherapy in the treatment of advanced digestive tract cancers
LI Hong,FAN Qing-xia,YANG Feng. Efficacy of hydroxycamptothecin combined with chemotherapy in the treatment of advanced digestive tract cancers[J]. Journal of Modern Oncology, 2007, 15(6): 819-820
Authors:LI Hong  FAN Qing-xia  YANG Feng
Affiliation:1The First Affiliated Hospital of Zhengzhou University ,Zhengzhou 450052, China;2Henan Provincial Tumor Hospital ,Zhengzhou 450008, China.
Abstract:Objective:To observe the efficacy and toxicity of hydroxycamptothecin(HCPT)in the treatment of advanced digestive tract tumors.Methods:Total of 119 patients with advanced digestive tract tumors were studied.According to their diseases,they were treated with hydroxycamptothecine plus different chemotherapy respectively for 4 cycles with interval of 21 days.Results:The total response rate was 54.6%,and the clinical response rate of patients with gastric cancer was 63.3%,which was the highest among the study patients.The adverse effects consisted of leukocytopenia and gastrointestinal reactions.Conclusion:Hydroxycamptothecin combined with chemotherapy is effective and safe to patients with advanced digestive tract cancers,no cross drug resistance to other anticancer drugs.
Keywords:HCPT
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号